Medtronic : Covidien Japan and HOGY Medical conclude a service agreement to commence cooperation on the sale of SuReFInD®

TOKYO - May 24, 2024 - Covidien Japan, Inc., (Head Office: Minato-ku, Tokyo), one of three Medtronic subsidiaries in Japan, concluded a service agreement on May 1 with HOGY Medical Co., Ltd. (Head Office: Minato-ku, Tokyo) to cooperate on the sale of SuReFInD®, a marking medical device used on lung cancer patients. HOGY Medical is a marketing authorization holder for the product. The sale cooperation activities will commence successively from June. HOGY Medical's SuReFInD®, which is used to [...]

This is an abstract of the document. To keep reading, click here and get access to the original version.